Dr. Weintraub received her BS in Psychology/Biology from McGill University, and a M.Ed in Learning Disabilities and PhD in Psychology, both from Boston University. She completed postgraduate training at the Beth Israel Hospital, Harvard Medical School, where she started the Clinical Neuropsychology service in Behavioral Neurology and became Associate Professor of Neurology. In 1994, she moved to Northwestern University Feinberg School of Medicine in 1994 where she is currently Professor of Psychiatry, Neurology and Psychology and directs the neuropsychology program and the Clinical Core of an NIA-funded Alzheimer’s Disease center. Dr. Weintraub was a scientific honoree at the Rita Hayworth Gala of the National Alzheimer’s Association in1997. She currently serves on the Alzheimer’s Disease Clinical Task Force, a special advisory committee to the NIA, that created the Uniform Data Set, a systematic data collection method used by all the NIA-funded AD centers. She is the Cognition Domain team leader for the NIH Toolbox: Assessment of Neurological and Behavioral Function, a NIH Blueprint project that has developed comprehensive measures of sensory, motor, cognitive and emotional functions to be used by investigators conducting large-scale, longitudinal and epidemiologic studies for individuals from age three to age eighty-five. Her current work focuses on the neuropsychology of dementia caused by frontotemporal lobar degeneration, including the clinical syndromes of behavioral variant frontotemporal dementia (bvFTD) and primary progressive aphasia (PPA).

Marsel Mesulam, MD- Director, Cognitive Neurology and Alzheimer’s Disease Center (CNADC), Feinberg School of Medicine.
Marsel Mesulam was born in Istanbul in 1945. He received the degrees of Bachelor of Arts in 1968 and Medical Doctor in 1972, both from Harvard University. He was appointed Professor of Neurology at Harvard Medical School where he founded and led the Behavioral Neurology Unit of Boston’s Beth Israel Hospital. In 1994 he was appointed the Dunbar Professor of Neurology and Psychiatry and the Director of the multidepartmental Cognitive Neurology and Alzheimer’s Disease Center at Northwestern University’s Feinberg School of Medicine in Chicago.
His research has addressed the neural connectivity of the monkey brain, the organization of human cholinergic pathways, the representation of cognitive functions by large-scale neurocognitive networks, and the neurobiology of dementias. He introduced a new method for tracing neural pathways by axonal transport, identified the source of cortical cholinergic pathways in the primate brain, and characterized a unique form of language-based dementia known as primary progressive aphasia.
He received the Javits Award from the National Institute of Neurological Disease and Stroke, the Director’s Award from the McKnight Foundation, the Wartenberg Lectureship Award from the American Academy of Neurology and the Lishman Award from the International Neuropsychiatry Association and the Bengt Winblad Life Achievement Award from the Alzheimer's Association. He has been included in multiple lists of “America’ Top Doctors” and “Chicago’s Best Doctors.”
His students and trainees hold leadership positions in the US and abroad. He has published more than 300 research papers and edited a popular textbook of Behavioral and Cognitive Neurology. He is a past Vice President of the American Association of Neurology and a past President of the Organization of Human Brain Mapping. His current research focuses on the functional imaging of neurocognitive networks and on the pathophysiology of focal dementias.

Canada Research Chair & Professor in Special Education & Adaptive Technology, Ontario Institute for Studies in Education in the University of Toronto; Professor of Psychiatry, University of Toronto; and Senior Scientist, Neurosciences & Mental Health Research Program, The Hospital for Sick Children, Canada

John Crawford is a Professor in the School of Psychology, College of Life Sciences and Medicine, King’s College, University of Aberdeen. He holds honorary appointments as a Consultant Clinical Neuropsychologist and Consultant Clinical Psychologist with the NHS; he is also an Adjunct Professor at the Flinders University of South Australia, where he was previously the Director of Julia Farr Neuropsychology Research Unit. He has a BSc (Stirling), an MSc (Aberdeen) and a PhD (Aberdeen) in psychology, is a Charted Clinical Psychologist, and a Fellow of the British Psychological Society (BPS). He was formerly Chief Examiner for the BPS Board of Examiners in Clinical Neuropsychology. Professor Crawford has published over 160 scientific papers which have attracted more than 4500 citations in the scientific literature. His research is wide ranging but is unified by his interest in the quantitative aspects of psychological measurement, particularly in neuropsychology. He has developed an extensive set of statistical methods for measurement and analysis of the single case for use in clinical practice and research. He is currently an Associate Editor/ Consulting Editor for five scientific journals

Dr. Grant Iverson is a Professor in the Faculty of Medicine, Department of Psychiatry, at the University of British Columbia. He served as the Chair for the Canadian Psychological Association Section on Clinical Neuropsychology from 2003-2010. He was a member of the Board of Governors of INS from 2008-2011. He serves as Vice Chair of the Policy and Planning Committee of the National Academy of Neuropsychology. He is a founding member of the Traumatic Brain Injury Subcommittee of the Defense Health Board, a civilian advisory board to the United States Secretary of Defense. Professor Iverson has published more than 220 empirical articles, reviews, and book chapters. For the past 15 years, he has conducted research relating to the reliability, validity, and clinical accuracy of neuropsychological assessment. He is the lead investigator in a multi-year, programmatic research effort relating to developing and evaluating new evidence-based psychometric criteria for mild cognitive impairment in psychiatry and neurology

George P. Prigatano, Ph.D. is the Newsome Chair of Clinical Neuropsychology at the Barrow Neurological Institute at St. Joseph’s Hospital and Medical Center, Phoenix, Arizona. He established the Section of Clinical Neuropsychology at the Institute in 1985. Since that time he has remained active in the neuropsychological assessment and rehabilitation of a wide variety of patients seen at the Institute. Dr. Prigatano is board-certified in Clinical Neuropsychology by the American Board of Professional Psychology and holds fellowship status in Division 40 (Clinical Neuropsychology) and Division 22 (Rehabilitation Psychology) of the American Psychological Association.
Dr. Prigatano has been recognized nationally and internationally for his clinical and research work. He has received awards from the American Psychological Association and the National Academy of Neuropsychology. He has been named Honorary Member of the Swedish Neuropsychological Society as well as the Finnish Neuropsychological Society.
His clinical, theoretical, and empirical work has resulted in numerous publications, including the following books: Neuropsychological Rehabilitation After Brain Injury (1986); Awareness of Deficit after Brain Injury: Theoretical and Clinical Issues (1991), co-edited with Daniel Schacter, Ph.D.; Principles of Neuropsychological Rehabilitation (1999); Clinical Neuropsychology and Cost Outcome Research: A Beginning (2003), co-edited with Neil Pliskin, Ph.D.; and The Study of Anosognosia (2010).
Dr. Prigatano’s work has emphasized the need to include a thorough understanding of brain behavior relationships, with basic understanding of psychodynamics and the learning history of an individual that produces the complex symptom pictures observed after brain injury.
His most recent effort has been to establish the Children’s Center for Neuropsychological Rehabilitation at the Barrow Neurological Institute.

Dr. Gioia is a pediatric neuropsychologist and the Chief of the Division of Pediatric Neuropsychology at Children’s National Medical Center, where he directs the Safe Concussion Outcome, Recovery & Education (SCORE) Program. He is an Associate Professor of Pediatrics and Psychiatry at the George Washington University School of Medicine. He has been the Principal Investigator of several multi-site CDC-funded research studies of mild TBI in children and adolescents. The focus of his research is the development and implementation of methods and tools of executive function and evaluation of post-concussion neuropsychological functioning and symptoms. He has developed a family of innovative tests of executive function, the Behavior Rating Inventory of Executive Function (BRIEF), that are now translated in over 30 languages and used worldwide. He is a major contributing author to the updated 2007 edition of the CDC’s Physician Toolkit for Mild Traumatic Brain Injury entitled “Heads Up: Brain Injury in your Practice” and the toolkits for parents and young athletes entitled “Heads Up: Concussion in Youth Sports” and for school personnel “Heads Up to Schools: Know Your Concussion ABCs.” Dr. Gioia was also a panel member of the 2008 International Concussion in Sport Group Consensus meeting in Zurich, and is currently on the American Academy of Neurology Sports Concussion Guideline Author panel. He has been active as well in state and federal legislation to ensure more universal application of established rules for youth concussion management addressing student and athlete needs.

Catherine Harmer, Professor of Cognitive Neuroscience, University of Oxford: "A cognitive neuropsychological model of antidepressant drug action". Catherine Harmer is a Professor of Cognitive Neuroscience in the University Department of Psychiatry in Oxford. Her interests are centred on mood disorders and their treatment using an interdisciplinary approach which spans experimental psychology, psychopharmacology and psychiatry. This approach has led to a novel theory of antidepressant drug action which has been heralded as a potential paradigm shift in the field. Catherine has published over 100 peer reviewed articles and has been awarded prizes for her work from the British Association for Psychopharmacology (BAP) and the British Journal of Psychiatry. She is also a council member of the BAP and an editorial board member for the Journal of psychopharmacology and Biology of Mood and Anxiety disorders.

Jennie Ponsford, BA (Hons), MA (Clin Neuropsych), PhD, MAPsS, is a Professor of Neuropsychology and Director of Research Degrees in the School of Psychology and Psychiatry at Monash University, Director of the Monash-Epworth Rehabilitation Research Centre at Epworth Hospital and Associate Director (Rehabilitation) of the National Trauma Research Institute in Melbourne, Australia. She has spent the past 30 years engaged in clinical work and research with individuals with traumatic brain injury (TBI), conducting research investigating outcomes following mild, moderate and severe TBI, factors predicting outcome, including genetic, age and injury-related factors, and rehabilitative interventions to improve outcome, as well as studies focusing specifically on fatigue and sleep changes, psychiatric and substance use following TBI, and has also pioneered the development of specialised TBI rehabilitation programs. She has published over 110 journal articles and book chapters on these subjects, as well as two books on the management of traumatic brain injury. She directs a doctoral training program in Clinical Neuropsychology at Monash University. Professor Ponsford is President-Elect of the International Neuropsychological Society, Past-President of the International Association for the Study of Traumatic Brain Injury and the Australian Society for the Study of Brain Impairment, is also currently on the Executive of the International Brain Injury Association. She serves on the Editorial Board of several journals, including the Journal of the International Neuropsychological Society Brain Injury, Neuropsychological Rehabilitation, the Journal of Head Trauma Rehabilitation, Brain Impairment and Rehabilitation.

Professorial Fellow, University of Melbourne
Director, Critical Care & Neuroscience Research, Murdoch Childrens Research Institute
Prof Anderson is a paediatric neuropsychologist of some 30 years experience. She started her career working at the Royal Children’s Hospital, Melbourne, Australia, where she worked as a clinician, and then Co-ordinator of Neuropsychology Services, until taking up a lectureship at the University of Melbourne. In 2002 she was appointed Professor/Director of Psychology at the Royal Children’ s Hospital, and in 2005 she took up an additional role with the Murdoch Children’s Research Institute, as Director, Critical Care & Neuroscience Research. Her interests are in disorders of childhood that impact on the central nervous system, including both developmental and acquired disorders, and child and parent-focussed interventions for this group. Her research group has established the Australian Centre for Child Neuropsychological Studies (CNS), at the Royal Children’s Hospital, Melbourne, Australia.
She serves as consulting editor on a number of international journals including the Journal of the International Neuropsychological Society, Child Neuropsychology and Developmental Neurorehabilitation. She has been Associate Editor of the APA journal, ‘Neuropsychology’ and is currently an Associate Editor for the Journal of Neuropsychology, a British Psychological Society Publication. She has published over 200 papers in peer-reviewed journals and four books in the field. She has obtained competitive research grants totalling over $15 million.
She has served on the Board of Governors of the International Neuropsychological Society, and is a fellow of the Academy of Social Sciences of Australia and a fellow of the Australian Society for the Study of Brain impairment.

Dr. Joseph T. Giacino is the Director of Rehabilitation Neuropsychology and Research Associate at Spaulding Rehabilitation Hospital, and has a joint appoint at Massachusetts General Hospital, a teaching affiliate of Harvard Medical School. Dr. Giacino’s clinical and research activities are centered on the development and application of novel assessment and treatment methods for individuals with severe acquired brain injury (ABI) and disorders of consciousness (DOC). In 1991, he published the first iteration of the Coma Recovery Scale- Revised (CRS-R), a neurobehavioral assessment measure that detects subtle signs of consciousness often missed on traditional bedside assessment. The CRS-R provided a methodology for systematic cataloguing behavioral features of patients with DOC and contributed to the identification of a new clinical syndrome termed, the minimally conscious state (MCS). Outcome studies conducted by Dr. Giacino and his colleagues have demonstrated that functional recovery at 1 year post-injury is significantly more favorable for patients with post-traumatic MCS relative to those in vegetative state (VS). He has served as co-chair of the Aspen Workgroup (responsible for developing the diagnostic criteria for MCS) and was co-lead author of the Mohonk Report, a Congressionally-sponsored initiative to establish recommendations for lifelong care of patients with DOC. He is currently chairing the VS/MCS Guideline Development Panel co-sponsored by the American Academy of Neurology, American Congress of Rehabilitation Medicine and Traumatic Brain Injury Model Systems. Dr. Giacino is involved in a variety of multidisciplinary efforts to characterize the pathophysiologic substrate underlying VS and MCS. He is principle investigator on a project funded by the National Institute on Disability and Rehabilitation Research (NIDRR) to develop novel fMRI paradigms to assess the integrity of language and visual processing networks in patients with DOC. This project yielded the first evidence that cortical networks mediating language and visuoperception are largely preserved in MCS and not in VS. He is also the PI of a 12-site clinical trial of amantadine hydrochloride (AH) funded through NIDRR’s Collaborative Projects award mechanism. The primary aim of this trial is to determine whether AH facilitates functional recovery in patients with prolonged disturbances in consciousness. Dr. Giacino is also Co-PI of an FDA-approved pilot study of deep brain stimulation aimed at promoting recovery of speech and motor functions in patients with chronic post-traumatic MCS. The results of the first subject to complete this trial were reported in Nature in 2007 and this publication was named “runner-up” for best paper by the National Association of Rehabilitation Research and Training Centers. Dr. Giacino is a Fellow of the National Academy of Neuropsychology and the American Congress of Rehabilitation Medicine (ACRM). He is currently President of the ACRM and has held a variety of leadership positions in this organization since 1989, including the Chair of the Committee on the Minimally Responsive Patient for a period of 8 years. In 2002, he received the Distinguished Member award from the ACRM. He is on the editorial board of the Journal of Head Trauma Rehabilitation and serves as an ad hoc reviewer for numerous journals including Archives of Physical Medicine and Rehabilitation, Brain, Lancet, Nature Reviews-Neuroscience and Neurology. He is deeply committed to advancing the science of consciousness by interleaving clinical observation, neurophysiologic measures and scientific method.

Dr. Knight received his BS in Physics from the Illinois Institute of Technology in 1970 and his MD from Northwestern University Medical School in 1974. After Neurology residency at the University of California at San Diego, he did post-doctoral research training at the Salk Institute for Biological Studies in the area of human neurophysiology. He was a faculty member in the Department of Neurology at the University of California at Davis School of Medicine from 1980-1998. In 1998 Dr. Knight moved to UC Berkeley to lead a program in human neuroscience. He is currently the Evan Rauch Professor of Neuroscience and Director of the Helen Wills Neuroscience Institute at UC Berkeley. His laboratory utilizes electrophysiological and MRI techniques in neurological and neurosurgical patients to delineate the role of prefrontal cortex in human cognitive and social behavior. His laboratory also records electrocorticographic activity from neurosurgical patients with subdural grid electrodes to delineate cortical mechanisms supporting behavior. He is also involved in developing neural prosthesis devices for motor and language restoration in patients with stroke or spinal cord injury using electrocorticographic recordings. Dr. Knight received the Jacob Javits Award from the National Institute of Neurological Disorders and Stroke for distinguished contributions to understanding neurological disorders, the IBM Cognitive Computing Award and the 2008 German Humboldt Prize in Neurobiology.

Donald Stuss is current President and Scientific Director (interim) of the Ontario Brain Institute; senior scientist, Rotman Research Institute, Baycrest; founding Director of the Rotman Research Institute, Baycrest (1989-2008); Vice-President Research of Baycrest Centre (1991 – 2004; 2006 - 2010); Reva James Leeds Chair in Neuroscience and Research Leadership (2001-2008); University of Toronto Professor of Psychology and Medicine (Neurology and Rehabilitation Science); past President of the International Neuropsychological Society (1994); registered psychologist (Ont); Diplomate, American Board of Professional Psychology-Clinical Neuropsychology. Honours: Fellow of Canadian Psychological Association, American Psychological Association (Divisions 3, 6, 20,40), American Psychological Society, and the Stroke Council of the American Heart and Stroke Association; Order of Ontario (2001); 2004 - the University of Toronto Faculty Award, Fellow of the Royal Society of Canada, and election to University Professor status at the University of Toronto; 2005 - Fellow, Canadian Academy of Health Sciences, and Fellow, American Association for the Advancement of Science; 2007 - F.J. McGuigan Lecture Award, American Psychological Foundation and American Psychological Association; 2008 - Michener Institute Honorary Diploma, The Michener Institute for Applied Health Sciences, Toronto; 2010 - Dr. Gonzalo Rodriquez Lafora Lecture, Spanish Neurological Society. Publications (as of 2010): books: 1 co-authored; 3 edited and 1 in press; over 185 peer-reviewed publications, including in press; 48 chapters; and over 270 invited scientific lectures and workshops. His primary emphasis is on the understanding and rehabilitation of the functions of the frontal lobes, in patients with focal lesions as well as in those with traumatic brain injury or dementia.

Edvard Moser (48) is the Director of the Kavli Institute for Systems Neuroscience and the Centre for the Biology of Memory at the Norwegian University of Science and Technology. Together with May-Britt Moser, he has since their group was established in 1996 studied how spatial location and spatial memory are computed in the brain. Their work culminated in the discovery of grid cells in the entorhinal cortex in 2005, which points to this brain region as a hub for the brain network that makes us find our way. Grid cells provide a metric to the brain’s spatial map and are likely to participate in computation of position based on self-motion. Together with his colleagues, Edvard Moser has also shown how a variety of other functional cell types in the entorhinal microcircuit contribute to representation of self-location, how the outputs of the circuit are used by memory networks in the hippocampus, and how episodic memories are separated from each other in the early stages of the hippocampal memory storage. Edvard Moser is a member of the Board of Reviewing Editors in Science and co-editor of Current Opinion in Neurobiology.

Christopher Giza graduated from Dartmouth College, received his M.D. from West Virginia University and completed his internship at the University of Pennsylvania. Dr. Giza then trained in Adult and Pediatric Neurology at UCLA, after which he spent 2 summers on the Search and Rescue team in Yosemite National Park. In 1998, he returned to UCLA for a postdoctoral fellowship at the Brain Injury Research Center, and joined the faculty in 2001. His research interests include neuroplasticity, recovery from injury, sport-related concussions and brain development. He runs the Pediatric TBI clinic at UCLA. His research is supported by grants from the NFL Charities, Child Neurology Foundation/Winokur Family Foundation, Today’s and Tomorrow’s Children Fund and the Thrasher Pediatric Research Foundation. He is Associate Professor of Pediatric Neurology and Neurosurgery at the David Geffen School of Medicine and Mattel Children’s Hospital at UCLA.

Trevor Robbins was appointed in 1997 as Professor of Cognitive Neuroscience and was elected to the Chair of Expt. Psychology (and HoD) at the University of Cambridge from October 2002. He is a Fellow of the British Psychological Society (BPS), the Academy of Medical Sciences, and the Royal Society (2005), which is the most prestigious of the U.K. science institutions. He has been President of the British Association for Psychopharmacology (1994-1996) and the European Behavioural Pharmacology Society (1992-1994), winning the latter Society’s inaugural Distinguished Scientist Award in 2001. He was the F. Kavli Distinguished International Lecturer at the Society for Neuroscience meeting in 2005 and he gave the Staglin Mental Health Music Festival Keynote address in 2008. He was recently jointly given the prestigious Distinguished Scientific Achievement Award for 2011 by the American Psychological Association (with his colleague BJ Everitt) - only 4 other UK psychologists have won this award in the last 60 years. He has been a member of Medical Research Council (UK) and chaired the Neuroscience and Mental Health Board from 1996 until 1999. He is one of the most highly cited neuroscientists according to ISI, having published nearly 700 full papers or chapters, and co-edited five books including Neurobiology of Addiction; New Vistas (OUP) 2010 and Decision-making , Affect and Learning (OUP). Currently, he directs the MRC/Wellcome Trust-funded ‘Behavioural and Clinical Neuroscience Institute’, the mission of which is to enhance translation from basic to clinical neuroscience.